Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S (LILY34) Price & Analysis

― Followers

LILY34 Stock Chart & Stats

R$197.53

R$0.16(0.08%)

Sep 18, 2026

―

Day’s Range― - ―

52-Week RangeR$126.72 - R$223.07

Previous CloseN/A

VolumeN/A

Average Volume (3M)47.97K

Market Cap

R$5.58T

Enterprise ValueR$607.60K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)2543.4

Beta-0.32

Next Earnings

Oct 29, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares Outstanding1,882,714,100

10 Day Avg. Volume26,387

30 Day Avg. Volume47,965

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S News

Lilly, Novo face lawsuits over GLP-1 vision loss risk, WSJ says

Some emerging scientific research points to an increased risk for GLP-1 patients to develop nonarteritic anterior ischemic optic...

6h ago

LLY

NVO

Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers

Eli Lilly (LLY) announced that the U.S. Food and Drug Administration has granted full approval to Inluriyo, an...

1d ago

LLY

U.S. weighs allowing most pharma licensing deals with China, Reuters says

The U.S. is working on rules for pharmaceutical companies investing in China that would likely preserve their ability...

1d ago

AZN

BMY

Eli Lilly price target raised to $1,284 from $1,273 at Guggenheim

Guggenheim analyst Seamus Fernandez raised the firm’s price target on Eli Lilly (LLY) to $1,284 from $1,273 and...

1d ago

CVS

LLY

Psychedelic: Definium’s LSD-based drug meets endpoints in GAD study

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

2d ago

LLY

PBM

Ginkgo Bioworks announces partnership with Lilly TuneLab

Ginkgo Bioworks (DNA) announced that its Ginkgo Datapoints offering has entered into a new agreement with Lilly TuneLab,...

3d ago

DNA

LLY

Twist Bioscience enters agreement with Lilly TuneLab

Twist Bioscience Corporation (TWST) announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by...

3d ago

LLY

TWST

Midday Fly By: Stocks see further pressure from higher bond yields

Stocks were lower on Tuesday, extending the pullback from the previous session on further pressure from higher bond...

4d ago

Ulta Beauty, Etsy upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

4d ago

AGL

CLS

Video: Futures point to further declines as oil prices, Treasury yields climb

The Fly has brought its to-the-moment stock market reporting to YouTube! Subscribe if you want to know how...

4d ago

FPS

LLY

Entera Receives $9 Price Target and New ‘Outperform’ Rating From Leerink Partners (NASDAQ: ENTX)

WSW, NY, September 18th, 2026, FinanceWire Entera Bio Ltd. (NASDAQ:ENTX) has been initiated with coverage by Leerink Partners,...

1d ago

LLY

ENTX

Eli Lilly Buy Rating Reiterated as Analyst Sees Multi‑Year Growth Upside, Maintains $1,400 December 2026 Price Target

J.P. Morgan analyst Chris Schott maintained a Buy rating on Eli Lilly & Co today and set a...

17d ago

LLY

Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)

WSW, NY, August 31st, 2026, FinanceWire The drugs that rebuild bone are locked inside a channel most patients...

19d ago

LLY

NVO

Eli Lilly Buy Rating Reiterated on Durable Incretin and Obesity Growth, Price Target Maintained at $1,344

Analyst Jason Gerberry from Bank of America Securities maintained a Buy rating on Eli Lilly & Co and...

29d ago

LLY

LILY34 FAQ

What was Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s price range in the past 12 months?

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S lowest stock price was R$126.72 and its highest was R$223.07 in the past 12 months.

What is Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s market cap?

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s market cap is R$5.58T.

When is Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s upcoming earnings report date?

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s upcoming earnings report date is Oct 29, 2026 which is in 40 days.

How were Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s earnings last quarter?

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S released its earnings results on Aug 05, 2026. The company reported R$0.02 earnings per share for the quarter.

Is Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S overvalued?

According to Wall Street analysts Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S pay dividends?

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S does not currently pay dividends.

What is Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s EPS estimate?

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S have?

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S has 1,882,714,100 shares outstanding.

What happened to Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S’s price movement after its last earnings report?

Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S reported an EPS of R$0.02 in its last earnings report. Following the earnings report the stock price went up 4.588%.

Which hedge fund is a major shareholder of Eli Lilly & Co Shs Unsponsored Brazilian Depository Receipts Repr 0.033333333 S?

Currently, no hedge funds are holding shares in BR:LILY34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology